Should the Pharmaceutical Benefits Advisory Committee extend the range of free nicotine replacement therapies available for Aboriginal and Torres Strait Islander people?
Robertson
Jan A
JA
MacLaren
David J
DJ
Clough
Alan R
AR
D000279:Administration, Cutaneous; D026683:Advisory Committees / Q000191:economics*; D001315:Australia / Q000453:epidemiology; D006801:Humans; D009313:National Health Programs / Q000458:organization & administration*; D009538:Nicotine / Q000008:administration & dosage / Q000600:supply & distribution*; D012867:Skin; D012907:Smoking / Q000191:economics / Q000208:ethnology; D000074606:Smoking Prevention
D009538:Nicotine